Entry Point Capital, LLC Aura Biosciences, Inc. Put Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AURA
# of Institutions
76Shares Held
40.3MCall Options Held
800Put Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$60.4 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$50.6 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$42.6 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$26.5 Million8.2% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$26.2 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $255M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...